An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.


June 23, 2021 — The Radiological Society of North America (RSNA) is inviting proposals from researchers for funding support to help gather and submit data to the Medical Imaging and Data Resource Center (MIDRC), an open-source database of COVID-19 related images and clinical data.

MIDRC funding will be awarded to sites with substantial COVID-19 imaging and clinical data who are committed to contributing their data to the MIDRC. Extracting and compiling a dataset for submission to MIDRC takes time, effort and some expertise. The awards enable recipients to select, process and submit data for use by the MIDRC research community. Preference will be given to sites with data representing diverse and vulnerable patient populations and other forms of data that are underrepresented in the MIDRC dataset.

“We recognize that some health care organizations don’t have access to the resources needed to contribute data,” said Curtis Langlotz, M.D., Ph.D., RSNA board liaison for information technology and annual meeting. “Support for those sites helps assure that the MIDRC datasets reflect the full diversity of the patient population.”

Funded by the NIH National Institute of Biomedical Imaging and Bioengineering through a contract awarded to the University of Chicago, MIDRC is spearheaded by RSNA, the American College of Radiology and the American Association of Physicists in Medicine (AAPM). The data collected for MIDRC is designed to foster research to help doctors better understand, diagnose, monitor and treat COVID-19 by offering an open access platform to collect, annotate, store and share medical images related to COVID-19.

Award recipients will receive up to $38,000 for a one- to two-year project. Funds can be applied to any institutional process or individual who can facilitate the data transfer. The funds are awarded in four payments over the project duration: 25% after project kickoff, 25% after Institutional Review Board (IRB) and privacy approval and 50% after data delivery.

The funding opportunity is open to all levels of U.S.-based investigators. Applications will be accepted until all available funding has been awarded. The application deadline for the first round of funding is July 15.

For more information: RSNA.org/Covid-19/MIDRC-funding-program


Related Content

News | Lung Imaging

March 27, 2023 — On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative ...

Time March 27, 2023
arrow
News | Radiology Business

March 27, 2023 — Swissray brand has a long history of pioneering digital x-ray technology. One of the first markets that ...

Time March 27, 2023
arrow
News | Nuclear Imaging

March 22, 2023 — A novel imaging modality that can visualize the distribution of medical radiopharmaceuticals with very ...

Time March 22, 2023
arrow
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
arrow
News | Digital Pathology

March 21, 2023 — Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and PathPresenter ...

Time March 21, 2023
arrow
News | Radiology Business

March 21, 2023 — Boston Imaging, a subsidiary of Samsung Electronics, Co. Ltd, appoints Eric Sumner as the new Digital ...

Time March 21, 2023
arrow
News | Digital Radiography (DR)

March 20, 2023 — A study by Emory Healthcare reports that Konica Minolta Healthcare’s Dynamic Digital Radiography (DDR) ...

Time March 20, 2023
arrow
News | X-Ray

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images ...

Time March 20, 2023
arrow
News | Artificial Intelligence

March 17, 2023 — A new paper published in the Journal of Medical Internet Research describes how generative models such ...

Time March 17, 2023
arrow
News | Radiopharmaceuticals and Tracers

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to ...

Time March 16, 2023
arrow
Subscribe Now